闲置资金理财

Search documents
金字火腿拟3亿闲置资金购低风险理财产品
Xin Lang Cai Jing· 2025-09-22 14:35
Core Viewpoint - The company has approved the use of up to 300 million yuan of idle funds to purchase low-risk financial products, aiming to enhance fund utilization efficiency and increase returns [1] Group 1: Investment Details - The investment period will not exceed 12 months from the date of board approval, and the funds can be rolled over within the approved limit [1] - The investment is intended to improve overall performance and provide greater returns for the company and its shareholders [1] Group 2: Risk Management - Although the products are classified as low-risk, there are still risks associated with market fluctuations, unpredictable returns, and operational monitoring [1] - The company will implement risk control measures, such as selecting high-safety products and tracking net values [1] Group 3: Impact on Operations - This investment will not affect the company's daily cash flow or the development of its main business [1] - The decision has been reviewed and approved by both the board of directors and the audit committee [1]
新巨丰拟用1.5亿元闲置募集资金及9亿元自有资金进行理财
Xin Lang Cai Jing· 2025-09-22 12:49
上述两项议案的具体内容,可详见同日披露于巨潮资讯网(www.cninfo.com.cn)的相关公告。同时, 保荐机构就这两项事项均出具了核查意见。 点击查看公告原文>> 声明:市场有风险,投资需谨慎。 本文为AI大模型基于第三方数据库自动发布,任何在本文出现的信 息(包括但不限于个股、评论、预测、图表、指标、理论、任何形式的表述等)均只作为参考,不构成 个人投资建议。受限于第三方数据库质量等问题,我们无法对数据的真实性及完整性进行分辨或核验, 因此本文内容可能出现不准确、不完整、误导性的内容或信息,具体以公司公告为准。如有疑问,请联 系biz@staff.sina.com.cn。 责任编辑:小浪快报 新巨丰(301296)于2025年9月22日召开第三届董事会第二十九次会议,审议通过两项重要理财议案。 在本次会议上,董事会全票通过《关于使用部分闲置募集资金进行现金管理的议案》。公司在不影响募 集资金投资计划正常进行的前提下,将使用最高不超过1.5亿元的暂时闲置募集资金进行现金管理。这 些资金将用于购买安全性高、流动性好且有保本约定的理财产品或存款类产品,现金管理期限自董事会 审议通过之日起12个月内有效,单笔 ...
新巨丰:拟使用额度不超过9亿元购买理财产品
Mei Ri Jing Ji Xin Wen· 2025-09-22 11:43
Group 1 - The company, New Jufeng, announced on September 22, 2025, that its board approved a proposal to use up to 900 million RMB of idle funds to purchase high-security, liquid financial products, with a maximum single product term of 12 months [1] - As of January to June 2025, New Jufeng's revenue composition was 97.3% from sterile packaging and 2.7% from other businesses [1] - The company's market capitalization is currently 3.8 billion RMB [2]
股市必读:大亚圣象(000910)9月19日主力资金净流出502.25万元,占总成交额12.59%
Sou Hu Cai Jing· 2025-09-21 19:41
Core Points - Daya Saintxiang (000910) reported a closing price of 8.24 yuan on September 19, 2025, with a 0.49% increase and a trading volume of 48,800 shares, amounting to a transaction value of 39.8844 million yuan [1] Trading Information Summary - On September 19, 2025, the net outflow of main funds was 502.25 million yuan, accounting for 12.59% of the total transaction value; the net outflow of speculative funds was 404.75 million yuan, accounting for 10.15%; while retail investors had a net inflow of 907.0 million yuan, accounting for 22.74% [1][3] Company Announcement Summary - The ninth meeting of the ninth board of directors of Daya Saintxiang was held on September 19, 2025, where two resolutions were passed: the adjustment of the members of the board's special committees and the approval to use idle self-owned funds to purchase government bond reverse repos and financial products [1][2] - The company approved the use of no more than 1.2 billion yuan of idle self-owned funds for investments in low-risk financial products, with a rolling investment period of 12 months from the date of board approval [2][3] - The first extraordinary general meeting of shareholders in 2025 was held on September 19, 2025, where resolutions to cancel the supervisory board and amend the company's articles of association were passed with a high approval rate [2][4]
广州鹿山新材料股份有限公司第六届董事会第三次会议决议公告
Shang Hai Zheng Quan Bao· 2025-09-18 20:29
Group 1 - The company held its sixth board meeting on September 18, 2025, where all five directors attended and approved key resolutions [2][4] - The board decided to exercise the early redemption of "Lushan Convertible Bonds" due to the stock price meeting the required conditions, specifically closing prices being above 130% of the conversion price for 15 trading days [3][35] - The company aims to reduce financial costs and optimize its capital structure through this redemption [3][36] Group 2 - The board approved an increase in the limit for using idle funds to purchase financial products from 650 million RMB to 750 million RMB [5][19] - The investment strategy was adjusted to include only financial products with a risk level not exceeding R3, ensuring safety and liquidity [10][19] - The company plans to use the idle funds efficiently while ensuring that normal operations are not affected [13][23] Group 3 - The "Lushan Convertible Bonds" were issued on March 27, 2023, with a total amount of 524 million RMB and a maturity of six years [27] - The conversion price has been adjusted multiple times, with the latest adjustment setting it at 16.05 RMB per share [30][35] - The company has triggered the conditional redemption clause of the bonds, allowing for early redemption under specified conditions [31][35]
天士力医药集团股份有限公司第九届董事会第14次会议决议公告
Shang Hai Zheng Quan Bao· 2025-09-17 20:09
1、关于使用闲置资金购买银行理财产品的议案 内容详见公司在上海证券交易所网站(www.sse.com.cn)发布的《关于使用闲置资金购买银行理财产品 的公告》(公告编号:临2025-062号)。 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码:600535 证券简称:天士力 编号:临2025-061号 天士力医药集团股份有限公司 第九届董事会第14次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性承担个别及连带责任。 天士力医药集团股份有限公司(以下简称"公司")第九届董事会第14次会议通知于2025年9月12日以书 面方式发出,会议于2025年9月17日下午13:30在公司会议室以现场会议方式召开,会议应到董事15人, 实到13人,董事王亮先生因工作原因书面委托董事王克先生代为行使表决权,董事原京先生因工作原因 书面委托董事席凯先生代为行使表决权,公司部分高管列席会议。会议符合《公司法》和《公司章程》 的有关规定,会议合法、有效。会议由公司董事长周辉女士主持,经与会人员逐项审议,通过了以下议 案: 表决情况为:有效 ...
昆药集团:拟以不超25亿元投资理财
Sou Hu Cai Jing· 2025-09-17 12:48
Core Viewpoint - Kunming Pharmaceutical Group Co., Ltd. plans to invest up to 2.5 billion yuan of idle self-owned funds in low to medium-risk financial products to enhance fund utilization efficiency and yield levels while ensuring operational capital needs and safety [1][5]. Investment Details - Investment Amount: 2.5 billion yuan [4] - Investment Type: Low to medium-risk financial products [4] - Source of Funds: Self-owned funds [4] Product Characteristics - The company intends to purchase high-security, low to medium-risk financial products (risk rating R2 and below), including bank wealth management products and structured deposits [5]. - The investment will not be directed towards high-risk securities market products such as stocks, bonds, funds, foreign exchange, and derivatives [5]. Investment Timeline - Investment period is within one year from the date of shareholder meeting approval, until October 9, 2026 [5]. - Each financial product's single investment term shall not exceed six months [5]. Company Background - Kunming Pharmaceutical Group was established in March 1951 and listed on the Shanghai Stock Exchange in December 2000 [5]. - The company has over 50 subsidiaries, including Kunming Traditional Chinese Medicine Factory and Kunming Huaren Shenghuo Pharmaceutical Co., Ltd. [5]. - In the first half of 2023, the company achieved operating revenue of 3.351 billion yuan and a net profit attributable to shareholders of 198 million yuan [5].
华润三九拟以合计不超100亿元自有资金投资理财产品
Bei Jing Shang Bao· 2025-09-17 11:57
Core Viewpoint - China Resources Sanjiu (华润三九) announced plans to invest up to 10 billion yuan in bank wealth management products to effectively utilize idle funds while ensuring operational safety and risk management [1] Investment Strategy - The company aims to invest a total of no more than 10 billion yuan of its own funds in bank and bank-affiliated wealth management products, excluding those from Zhuhai China Resources Bank [1] - The investment will focus on medium to low-risk financial products and structured deposits, ensuring that it does not affect the company's main business operations [1] Risk Management Principles - The company adheres to principles of "standardized operations, risk prevention, cautious investment, and value preservation and appreciation" [1] - The strategy is designed to generate investment returns for shareholders while maintaining the safety of the company's daily operations and funds [1]
昆药集团:拟使用25亿元闲置自有资金进行投资理财
Mei Ri Jing Ji Xin Wen· 2025-09-17 10:57
Group 1 - The company plans to invest up to 2.5 billion yuan of idle funds in low to medium-risk financial products [1] - The investment decision has been approved by the board of directors and the supervisory board, pending shareholder meeting approval [1] - The investment period is set to be within one year from the date of shareholder meeting approval, with funds being reusable [1] Group 2 - The company's financial and operational management center will conduct risk, direction, and return assessments of the financial products according to the company's cash management system [1] - A ledger will be established to enhance regular tracking and management, with a strong emphasis on risk control [1]
岩山科技(002195)披露使用闲置自有资金进行投资理财进展公告,9月17日股价下跌2.38%
Sou Hu Cai Jing· 2025-09-17 09:40
截至2025年9月17日收盘,岩山科技(002195)报收于8.61元,较前一交易日下跌2.38%,最新总市值为 488.23亿元。该股当日开盘8.72元,最高8.82元,最低8.55元,成交额达65亿元,换手率为13.44%。 以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成 投资建议。 最新公告列表 《关于使用闲置自有资金进行投资理财的进展公告》 公司近日发布公告,披露了使用闲置自有资金进行投资理财的进展情况。根据公告,上海岩山科技股份 有限公司于2025年5月30日召开董事会及监事会,于2025年6月24日召开股东大会,审议通过使用不超过 60亿元闲置自有资金进行委托理财,有效期12个月,额度可滚动使用。近期新增购买多款理财产品,包 括ETF、FOF资产管理计划、私募基金、结构性存款及国债逆回购等,投资主体涵盖公司及控股子公 司,合计金额107,161.31万元,资金来源均为闲置自有资金,产品类型主要为非保本浮动收益型和保本 浮动收益型。公司已制定风险控制措施,包括授权管理层决策、内部审计监督、独立董事检查等。截至 公告日,前十二个月内累计 ...